ACC,
Alliance Highlight Concerns About E-Prescribing, Drug Payments
in Medicare Reform Debate
In letters to House and Senate members of the conference committee
debating Medicare reform legislation, the Alliance of Specialty
Medicine, of which the ACC is a member, urged the conferees
to address several issues that could directly affect physicians.
The Alliance noted concerns about provisions in the legislation
that would mandate electronic prescribing, a move the Alliance
stressed would be unworkable for many smaller practices and
practices in rural areas and be plagued with problems such
as lack of data integrity, improper drug substitutions, and
increased economic stress on physician practices. In separate
letters, the Alliance urged conferees to work toward a more
long-term fix to physician Medicare payment problems and to
ensure that any efforts to increase practice expense payments
to oncologists for the administration of outpatient oncology
drugs, as a result of reductions in the average wholesale
price of outpatient drugs, do not unfairly penalize other
physician specialties.
Cardiologists
Would Benefit Under Medicare Part B Drug Payment Rule
Practice expense relative values for cardiology services
would receive a 3 percent increase under a proposed rule published
in the Federal Register on August 20.The payment
reform for Part B drugs: (1) solicits comments on four options
to cut the price of drugs administered in physicians' offices
by about 10 percent; (2) increases practice expense payments
for oncologists and cardiac and thoracic surgeons; (3) removes
clinical oncology from the nonphysician work pool (NPWP);
and (4) increases practice expense relative values by approximately
3 percent for those procedures (including cardiovascular procedures
with a separate technical component payment) remaining in
the NPWP. Under the rule, payments for the pharmacological
stress agents adenosine, dipyridamole, and dobutamine used
by cardiologists in approximately 40 percent of stress tests
would be lowered, but radiopharmaceuticals used by nuclear
cardiologists and contrast agents employed by echocardiographers
will not be affected by these changes because they are not
classified as drugs.
Electronic
Claims Only to Medicare After Oct. 16
The CMS has reiterated that only electronic claims
will be accepted and paid by Medicare beginning on Oct. 16—the
deadline for compliance with the transaction and code set
regulations. Some small providers are exempted from this requirement.
In an interim final rule, the CMS notes that there are very
few exceptions to the electronic-only edict, including interruptions
in electronic claims submission mechanisms that are outside
a provider’s control or "extraordinary circumstances
precluding submission of electronic claims." Last week,
the ACC began a series of meetings on Capitol Hill to discuss
the need for further clarification from the CMS on its policies
and interpretation of the transactions and code sets rule.
For more information, visit the ACC
HIPAA Resource Center.
Texas
Physicians Pushing Proposition to Allow Noneconomic Damage
Caps
Texas Gov. Rick Perry, R, has joined calls from physician
groups in the state urging the public to vote in favor of
a ballot measure on medical liability reform. The measure,
Proposition 12, would allow the state's constitution to be
amended to allow laws that place caps on noneconomic damages
in medical liability lawsuits. The vote on the ballot measure
vote is scheduled for Aug. 27. The ACC Texas Chapter has worked
closely with the Texas Medical Association on medical liability
reform efforts and has been deeply involved in fundraising
and other activities to encourage the public to vote in favor
of Proposition 12.
First
OIG Review of Cardiac Rehab Finds Lack of Physician Oversight
In the first of a series of reviews of Medicare payments for
hospital outpatient cardiac rehabilitation services, the HHS
Office of Inspector General (OIG) faulted Saint Luke’s
Medical Center in Milwaukee on several fronts. The CMS requested
that the OIG review cardiac rehab services at facilities across
the country. The goal of these studies is to assess the amount
of physician involvement in cardiac rehabilitation, which
is currently covered as a physician service. In the review,
the OIG faulted the hospital for failing to designate a physician
to directly supervise the cardiac rehab services and said
that it could often not identify the physician professional
services to which the cardiac rehabilitation services were
provided “incident to.” The OIG estimated that
the hospital claimed and received more than $47,000 in improper
Medicare reimbursement for outpatient cardiac rehabilitation
services. The ACC is developing a response to this report.
Appropriations
Amendments Would Significantly Increase NIH Funding
ACC members are encouraged to contact their senators in support
of efforts to increase NIH funding for FY 2004. As currently
written, the Senate HHS appropriations bill would give the
NIH about a 3.7 percent boost in FY ’04, or approximately
$1 billion. The House bill, which has already been passed,
includes a similar increase. An amendment to the Senate appropriations
bill to be introduced by Sens. Arlen Specter, R-Pa., Tom Harkin,
D-Iowa, and Dianne Feinstein, D-Calif., would increase funding
for the NIH by 9.2 percent over the current level of $26.9
billion. The amendment will be debated as early as September
2. ACC members can easily contact their senators using the
ACC grassroots
advocacy tool on the ACC Web site or by calling toll-free
at (877) 432-7841.
Specialty
Hospitals Trying to Oust Medicare Reform Bill Language Limiting
MD Involvement
Specialty hospital groups are engaged in a pitched lobbying
battle to eradicate language in the Medicare reform legislation
being debated in Congress that would limit physician investment
in such hospitals. The enactment of the limitation, some analysts
have said, would be the death knell for the burgeoning industry.
While the House-passed Medicare bill calls for more study
of specialty hospitals and their role in patient care, the
Senate bill includes a provision that would prevent physicians
from referring patients to specialty hospitals in which the
physicians have an interest. It would exclude those hospitals
already in existence or under construction as of June 12,
2003. According to a Health News Daily report, both
The MedCath Corporation, which owns and operates many cardiovascular
care hospitals, and the American Surgical Hospital Association
have been active in opposing the Senate bill. The American
Hospital Association has launched its own campaign in favor
of the Senate bill provision.
FDA
Warns Philips About MR Device Cardiac Perfusion Promotional
Language
The FDA has issued a warning letter to Philips Medical Systems
about “false and misleading” information in promotional
language about its Intera magnetic resonance imaging device.
The language is misleading, the warning
letter states, because it “implies that these devices
have been cleared or approved by FDA for use with contrast
agents in cardiac perfusion.” The letter cites several
places on the Philips Web site where use of the device for
cardiac perfusion studies is discussed. “Philips has
not been granted clearance or approval from FDA for use of
these devices for cardiac perfusion,” the letter states,
“and there are currently no contrast agents approved
for use in imaging of the heart in the United States.”
The agency gave Philips 15 days to submit the corrective actions
it plans on taking in light of the letter.
Advocacy
Weekly will not be published next week because of the
Labor Day holiday.
Advocacy
Weekly is a product of the Advocacy Division of the American
College of Cardiology. Questions or comments regarding this
publication should be directed to the Advocacy Division at
800-435-9203 or to advocacydiv@acc.org. |